Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 5,000 shares at $255.05 ($1.3M) on 2018-09-04, disclosed to the SEC on 2018-09-06.
Open-market sale of $1.3M LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2023-05-12 | $988K | — | Filing → |